COMMUNIQUÉS West-GlobeNewswire

Scholar Rock to Present Preclinical Data Highlighting the Role of TGFβ1 Inhibition in Overcoming Checkpoint Resistance at the SITC Annual Meeting
01/10/2018
CAMBRIDGE, Mass., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental [...]
Acasti Pharma Announces Issuance of Common Shares in Payment of Outstanding Interest under Debentures
01/10/2018
LAVAL, Québec, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), today announced its election to issue common shares to the holders of its outstanding [...]
Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results
01/10/2018
SOUTH SAN FRANCISCO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, announced today that it will report third quarter financial [...]
Aduro Biotech Announces Four Abstracts Accepted for Presentation at the 2018 Society for Immunotherapy of Cancer (SITC) Annual Meeting
01/10/2018
Preliminary Phase 1 data for novel STING pathway activator ADU-S100 (MIW815) accepted for presentation BERKELEY, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that four [...]
Aclaris Therapeutics Launches Direct-to-Consumer Campaign for ESKATA® (hydrogen peroxide) Topical Solution 40%, (w/w)
01/10/2018
ESKATA is the First and Only FDA-Approved Topical Treatment for Raised Seborrheic Keratoses WAYNE, Pa., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical [...]
GW Pharmaceuticals Announces Proposed Public Offering of ADSs
01/10/2018
LONDON and CARLSBAD, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]
Merit Medical Signs Agreement to Acquire Cianna Medical, Inc.
01/10/2018
SOUTH JORDAN, Utah, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Allscripts to present at the 2018 Cantor Fitzgerald Global Healthcare Conference
01/10/2018
CHICAGO, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX) today announced that certain members of its management team will present at the 2018 Cantor Fitzgerald Global Healthcare Conference in New York, NY on [...]
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/10/2018
BOSTON, Oct. 01, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline [...]
Align Technology to Announce Third Quarter 2018 Results on October 24, 2018
01/10/2018
SAN JOSE, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report third quarter 2018 financial results on Wednesday, October 24, 2018 after the close [...]
Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment
01/10/2018
Retrospective trial utilizing intraoperative radiation therapy with the revolutionary Xoft System shows recurrence rates to be comparable to cornerstone TARGIT-A Trial at mean follow-up 4.6 years NASHUA, N.H., Oct. 01, [...]
Essilor et Delfin finalisent le rapprochement d'Essilor et de Luxottica en créant EssilorLuxottica, un leader mondial de l'optique ophtalmique et de la lunetterie
01/10/2018
Essilor et Delfin finalisent le rapprochement d'Essilor et de Luxottica en créant EssilorLuxottica, un leader mondial de l'optique ophtalmique et de la lunetterie Version PDF du communiqué EssilorLuxottica regroupe deux [...]
SAVI SCOUT® Highlighted as a Cutting Edge Technology for Breast Cancer Patients in 2018
01/10/2018
ALISO VIEJO, Calif., Oct. 01, 2018 (GLOBE NEWSWIRE) -- The SCOUT® Radar Breast Localization System was featured as the 2018 cutting edge technology for breast cancer patients as Good Morning America kicked off Breast [...]
Sanofi: Disclosure of trading in own shares
01/10/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
01/10/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Transactions in relation to share buyback program
01/10/2018
Announcement no. 57/2018 1 October 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]
OSE Immunotherapeutics to Present at the 18th Annual Biotech in Europe Investor Forum
01/10/2018
Oct. 4-5, 2018, Congress Center Basel NANTES, France, Oct. 01, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnémo: OSE) announced today that Alexis Peyroles, chief executive officer, will [...]
NICOX : MONTHLY PUBLICATION OF THE NUMBER OF SHARES COMPOSING THE SHARE CAPITAL AND OF THE TOTAL NUMBER OF VOTING RIGHTS
01/10/2018
Nicox SA Société anonyme with a registered capital of € 29,715,320 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On October 1, 2018, MONTHLY PUBLICATION OF THE [...]
NICOX : PUBLICATION MENSUELLE DU NOMBRE D'ACTIONS COMPOSANT LE CAPITAL ET DU NOMBRE TOTAL DE DROITS DE VOTE
01/10/2018
Nicox SA Société anonyme au capital de 29 715 320 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 1 octobre 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]

Pages